S. S. Yakushin

Acetazolamide per os in Decompensated Chronic Heart Failure: Randomized Multicenter Trial ORION-A

И. С. Сабиров, О. А. Рубаненко, S. V. Villevalde, А. О. Рубаненко et autres

Background/Objectives: Overcoming resistance to diuretics is extremely important in decompensated chronic heart failure (HF). The objective of this study was to assess the efficacy and safety of oral acetazolamide, in addition to standard therapy, in HF patients admitted to the hospital with …

kg, ru (code pays fourni par la source)

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash et autres

us, ch, ca, sg, pl, it, co, de, nl, fr (code pays fourni par la source)

Relationship of Iron Deficiency, Anemia and Combination of Iron Deficiency With Anemia With Severity of Manifestations of Chronic Heart Failure. Additional Analysis of the Study “Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)”

Zhanna Kobalava, Yu. V. Mareev, Yu. L. Begrambekova, L. V. Karapetyan et autres

Aim To evaluate the role of iron deficiency (ID) identified by various criteria, anemia, and the combination of ID and anemia in determining the severity of the clinical course of chronic heart failure (CHF) in a retrospective analysis of data from 498 …

ru (code pays fourni par la source)

EPOCH-CHF As A Mirror of the Current Problems in Cardiovascular Diseases Treatment in Real Clinical Practice

И. В. Фомин, Yu. N. Belenkov, Mareev VIu, Ф. Т. Агеев et autres

Aim To analyze the main reasons for the impairment of the life prognosis of patients with chronic heart failure (CHF) in real clinical practice of the Russian Federation.Material and methods Representative samples of the population of the Nizhny Novgorod region (1998, n=1,922) …

ru, us (code pays fourni par la source)

2024 Clinical practice guidelines for Chronic heart failure

А. S. Galyavich, S. N. Tereshchenko, F. T. Ageev, D. M. Aronov et autres

Russian Society of Cardiology (RSC) With the participation: National Society of Myocardial Diseases and Heart Failure, Society of Heart Failure Specialists, Russian Scientific Medical Society of Internal Medicine Endorsed by the Research and Practical Council of the Ministry of Health of the …

In Search of Optimal Criteria for Iron Deficiency in CHF Patients. Post-hoc Analysis of the Study “Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (ID-CHF-RF)”

Yu. V. Mareev, Ж. Д. Кобалава, Yu. L. Begrambekova, L. V. Karapetyan et autres

AIM: Comparative analysis of clinical, anamnestic, and laboratory and instrumental data of patients with chronic heart failure (CHF) and iron deficiency (ID) diagnosed according to the AHA/ESC/RSC criteria, and CHF patients diagnosed with ID based on decreased transferrin saturation (TSAT) ≤19.8% or …

ru (code pays fourni par la source)

2024 Clinical practice guidelines for Stable coronary artery disease

О. Л. Барбараш, Yu. A. Karpov, A. V. Panov, R. S. Akchurin et autres

Russian Society of Cardiology (RSC) With the participation of: the National Society for the Study of Atherosclerosis (NOA), the Atherothrombosis National Society, the Russian Association of Cardiovascular Surgeons, the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RosOKR), the Russian Society of …

Female and Male Phenotypes of Iron Deficiency in CHF. Additional analysis of the «The Prevalence of Iron Deficiency in Patients With Chronic Heart Failure in the Russian Federation (J-CHF-RF)» study

Yu. L. Begrambekova, Yu. V. Mareev, Mareev VIu, Yа. A. Orlova et autres

Aim To evaluate the incidence of iron deficiency (ID) in men and women with chronic heart failure (CHF) and to compare clinical and functional indexes in patient with and without ID depending on the gender.Material and methods An additional analysis of the …

ru (code pays fourni par la source)

Disorders of lipid metabolism. Clinical Guidelines 2023

М. В. Ежов, В. В. Кухарчук, И. В. Сергиенко, А. С. Алиева et autres

The Russian Society of Cardiology (RKO) With the participation of: The National Society for the Study of Atherosclerosis (NOA), the Russian Association of Endocrinologists (RAE), the Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RosOKR), the Russian Scientific Medical Society of Therapists …

Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders

S. А. Shalnova, V. A. Metelskaya, В. А. Куценко, Е. B. Yarovaya et autres

Aim. To perform a population analysis of Non-High Density Lipoprotein Cholesterol level (non-HDL-c) in Russian population and to evaluate its association with cardiovascular events. Material and Methods. The material consisted of results obtained from 11 regions of the ESSE-RF1 Study and from …

ru (code pays fourni par la source)

Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes

M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin et autres

Aim. To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial fibrillation (AF) and chronic heart failure (CHF) based on prospective registries of patients with cardiovascular diseases (CVD). Materials and Methods. The …

ru (code pays fourni par la source)

REGIONAL MEDICAL AND EDUCATIONAL ANTISMOKING CAMPAIGN AS AN ELEMENT OF THE POPULATION STRATEGY TO QUIT SMOKING

V.I. Seregin, G.B. Artemyeva, S. S. Yakushin

Significance. Tobacco smoking is one of the most important problems of public health. It is quite obvious that the prevention of tobacco consumption needs a comprehensive and systematic implementation of a wide range of multi-level and intersectoral measures, the essence of which …